ADAA: Sertraline Effective for Treating Social Anxiety Disorder
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




ADAA: Sertraline Effective for Treating Social Anxiety Disorder

By Alison Palkhivala

TORONTO, ON -- March 31, 2003 -- Sertraline (Zoloft) helps improve quality of life and functioning in patients with social anxiety disorder, especially among patients with severe impairment.

Michael Liebowitz, MD, from the Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, presented the findings here in a poster on March 29th at the 23rd Annual Conference of the Anxiety Disorders Association of America (ADAA).
Dr. Liebowitz and colleagues randomized 415 outpatients with social anxiety disorder to 12 weeks of therapy with 50 to 200 mg/day of sertraline or a placebo. They assessed patients' quality of life and level of functioning using the Quality of Life, Enjoyment, and Satisfaction scale (Q-LES-Q), the Sheehan disability inventory (SDI) and the Endicott work productivity score (EWP).

At baseline, 32% of patients had normal scores on the Q-LES-Q. By the end of the 12 weeks, 61% of patients taking sertraline and 46% of those on placebo had normal scores on this scale (P=0.016). Among patients who were more than one standard deviation below the community mean at baseline, 49% had normal scores by week 12 in the sertraline group, compared with 29% in the placebo group (P=0.0273).

Sertraline therapy also resulted in significant improvement in the SDI compared with placebo, and there was a trend toward more improvement in the EWP in those taking sertraline compared with placebo.

Dr. Liebowitz concluded that patients who are chronically ill with social anxiety disorder -- even for as long as 20 years -- can respond to 12 weeks of treatment with sertraline and improve their ability to function as well as the way they feel.

[Study title: Efficacy of Sertraline in Improving Disability and Quality of Life Impairment in Severe Social Anxiety Disorder. P117]

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities